Kim Tang

This inventor holds 1 USPTO granted patent. Top assignee: Dyne Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kim Tang. Retrieved from https://idiyas.com/inventor/kim-tang-1njym8e0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kim Tang: Innovator in Myotonic Dystrophy Treatment

Introduction

Kim Tang is a notable inventor recognized for her contributions to the field of medical science, particularly in the treatment of myotonic dystrophy. She has developed innovative solutions that aim to improve the quality of life for individuals affected by this condition.

Latest Patents

Kim Tang holds a patent for "Muscle Targeting Complexes and Formulations for Treating Myotonic Dystrophy." This patent represents her commitment to advancing therapeutic options for patients suffering from this genetic disorder. She has 1 patent to her name, showcasing her innovative approach to addressing complex medical challenges.

Career Highlights

Currently, Kim Tang is employed at Dyne Therapeutics, Inc., where she continues to work on groundbreaking research and development projects. Her role at the company allows her to collaborate with other experts in the field and contribute to significant advancements in therapeutic formulations.

Collaborations

One of her notable collaborators is Timothy Weeden, who works alongside her at Dyne Therapeutics, Inc. Together, they strive to push the boundaries of current medical treatments and explore new avenues for research.

Conclusion

Kim Tang's work in developing treatments for myotonic dystrophy exemplifies her dedication to innovation in the medical field. Her contributions are paving the way for future advancements that could greatly benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…